Accessibility Menu

Grand Pharmaceutical Group(SEHK) 512

Market CapHK$18.35BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1996)-20%
5 Year-19%
1 Year-7%
1 Month-3%
HK$6,408.24
-0.85%
-54.89Today
Grand Pharmaceutical Group last closing stock price
MetricPriceDate
Last closeHKD 6,410.242026-09-01
Grand Pharmaceutical Group stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-0.03%HKD 6,412.062026-08-25
1 month-2.61%HKD 6,581.912026-07-31
3 month-2.82%HKD 6,596.042026-06-03
Year to date-6.53%HKD 6,857.852025-12-31
1 year-7.28%HKD 6,913.662025-09-01
3 year+25.23%HKD 5,118.582023-09-01
5 year-19.44%HKD 7,957.062021-09-02
Since inception-19.69%HKD 6.531996-01-05

Grand Pharmaceutical Group Financials at a Glance

Market Cap

HK$18.35BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

N/A

Net Income (TTM)

N/A

EPS (TTM)

HK$0.32

P/E Ratio

16.19

Dividend

HK$0.17

Beta (Volatility)

0.01 (Low)

Price

HK$6,408.24

Volume

864,410,014

Open

HK$6,415.81

Previous Close

HK$6,463.12

Daily Range

HK$6,385.34 - HK$6,456.69

52-Week Range

HK$4.53 - HK$6,464.35

Estimated Earnings Date

N/A

512 News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Grand Pharmaceutical Group

China Grand Pharmaceutical and Healthcare Holdings Limited

Industry

Pharmaceuticals

Sector

Health Care

Employees

12,614

CEO

Chao Zhou

Website

www.grandpharma.cn

512 Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

6.59%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

6.18%

Dividend Yield

3.23%

Payout Ratio

N/A

Stock Overview

Market Cap

HK$18.35BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

3.50B

Volume

864.41M

Avg. Volume

5.64M

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Grand Pharmaceutical Group Performance Analysis

Grand Pharmaceutical Group annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31HKD 9,562,285,00011.2%
20232023-12-31HKD 10,529,590,00010.1%
20242024-12-31HKD 11,644,892,00010.6%
20252025-12-31HKD 12,283,271,0005.5%
Grand Pharmaceutical Group annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31HKD 0.59-13.3%
20232023-12-31HKD 0.54-8.7%
20242024-12-31HKD 0.7031.5%
20252025-12-31HKD 0.35-49.7%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
CurrentYOY CHG

Revenue

N/A

N/A

Gross Profit

N/A

N/A

Gross Margin

N/A

N/A

Market Cap

HK$18.35BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

N/A

N/A

EBITDA

N/A

N/A

Quarterly Fundamentals

Name
CurrentYOY CHG

Total Cash

N/A

N/A

Total Debt

N/A

N/A

Accounts Receivable

N/A

N/A

Inventory

N/A

N/A

Long Term Debt

N/A

N/A

Short Term Debt

N/A

N/A

Return on Assets

N/A

N/A

Return on Invested Capital

N/A

N/A

Free Cash Flow

N/A

N/A

Operating Cash Flow

N/A

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,684.24-0.00%
^DJIDJI
$53,254.61-0.01%
^IXICNASDAQ
$26,319.55-0.00%
BTCBitcoin
$78,890.00-0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
PCGPG&E
$13.27-0.20%
NVDANvidia
$220.78+0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.97+0.11%
CNHCNH Industrial
$11.83+0.01%

Questions About 512

What is the current price of Grand Pharmaceutical Group?

Grand Pharmaceutical Group is trading at HK$6,408.24 per share.

What is the 52-week range for Grand Pharmaceutical Group?

Over the past 52 weeks, Grand Pharmaceutical Group has traded between HK$4.53 and HK$6,464.35.

How much debt does Grand Pharmaceutical Group have?

As of the most recent reporting period, Grand Pharmaceutical Group reported total debt of HK$4.72B.

How much cash does Grand Pharmaceutical Group have on hand?

Grand Pharmaceutical Group reported HK$1.16B in cash and cash equivalents in its most recent financial results.

What is Grand Pharmaceutical Group’s dividend yield?

Grand Pharmaceutical Group currently has a dividend yield of 3.23%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services